Recent Posts
Connect with:
Sunday / June 16.
HomeminewsSave Sight Launches Keratoconus Registry

Save Sight Launches Keratoconus Registry

A National Keratoconus registry will provide insights into different treatment approaches and enable more clinicians to benchmark and continuously improve their own patient outcomes.

Conceived by Save Sight Institute, a research centre of The University of Sydney, and based on the Fight Retinal Blindness project, led by Professor Mark Gillies also from the Save Sight Institute, the Registry will collect high quality data and outcomes from emerging therapies and surgical techniques relating to the management of Keratoconus.

It is anticipated that the Registry will be expanded internationally.

The project, which is being led by Save Sight Institute’s Clinical Professor Stephanie Watson, in collaboration with the Centre for Eye Research Australia in Melbourne, involves the development of a software platform to enable the mass collection of anonymous patient data in real-life clinical settings.
It is a clear example of how research can be embedded within healthcare delivery, a key recommendation of the 2013 McKeon Strategic Review of Health and Medical Research.

Once established, the registry will evaluate the clinical and patient-reported outcomes from emerging therapies

According to Prof. Watson, “many therapies, devices and surgical procedures have been developed to treat Keratoconus, but few have been evaluated using post -market surveillance, and there is no system in place to collect such data nationally. Keratoconus tends to affect young adults and has a significant public health impact”.

The first treatment to be evaluated via the registry is cross-linking, a relatively new approach to halting keratoconus progression. Following evaluation of cross-linking treatment protocols, the registry will obtain long-term data on cross-linking, as well as emerging treatments such as the combination of cross-linking with laser and the use of rings. Once established, the registry will evaluate the clinical and patient-reported outcomes from emerging therapies.

Seed funding for the Australian Keratoconus Registry was made possible because of the generosity of patient Larry Kornhauser, who made a $50,000 donation in memory of his late mother, Bettie Kornhauser.

“I was diagnosed with Keratoconus when I was 12 and my mother accompanied me to every eye appointment throughout my adolescence and beyond, including my corneal transplant operation,” said Mr. Kornhauser. “She would be honoured to be a part of this project which will hopefully lead to better treatments for adolescents with Keratoconus. Bettie was a committed philanthropist, past president of the Victorian Citizens Advice Bureau, founder of Wear for Success Melbourne and a supporter of numerous not-for – profits and awards to assist disadvantaged young people succeed in their lives.”

Keratoconus reduces vision by altering the biomechanical properties of the cornea. It affects 50 – 200 people per 100,000 of the general population. Severe visual deterioration affects 20 per cent of keratoconics and usually occurs in the second and third decades of life due to astigmatism, corneal scarring or both. As it affects young adults, it has a significant public health impact. If vision loss from Keratoconus cannot be corrected by spectacles or contact lenses, corneal grafting may be needed, which involves a life-long risk of graft rejection and weakening of the structural integrity of the eye.